Is the EQ-5D fit for purpose in mental health?
- PMID: 21037210
- DOI: 10.1192/bjp.bp.110.082453
Is the EQ-5D fit for purpose in mental health?
Abstract
The EQ-5D is a widely used questionnaire for calculating quality-adjusted life-years (QALYs) for assessing cost-effectiveness in healthcare. It reflects the impact of common mental health conditions such as mild to moderate depression but seems to be more problematic for use in people with psychotic and severe and complex non-psychotic disorders.
Comment on
-
Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders.Br J Psychiatry. 2010 Nov;197(5):386-94. doi: 10.1192/bjp.bp.109.076489. Br J Psychiatry. 2010. PMID: 21037216
Similar articles
-
Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.Value Health. 2022 Jun;25(6):1018-1029. doi: 10.1016/j.jval.2021.11.1358. Epub 2022 Jan 13. Value Health. 2022. PMID: 35667775 Clinical Trial.
-
Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders.Health Qual Life Outcomes. 2010 May 5;8:47. doi: 10.1186/1477-7525-8-47. Health Qual Life Outcomes. 2010. PMID: 20444251 Free PMC article. Clinical Trial.
-
The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study.J Clin Epidemiol. 2025 Jan;177:111592. doi: 10.1016/j.jclinepi.2024.111592. Epub 2024 Nov 7. J Clin Epidemiol. 2025. PMID: 39515489
-
Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented?Int J Technol Assess Health Care. 2014 Jan;30(1):10-19. doi: 10.1017/S0266462313000640. Int J Technol Assess Health Care. 2014. PMID: 24499622 Review.
-
Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments.Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-19. doi: 10.1586/14737167.2016.1146594. Epub 2016 Feb 18. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26808097 Review.
Cited by
-
Associations between readmission and patient-reported measures in acute psychiatric inpatients: a study protocol for a multicenter prospective longitudinal study (the ePOP-J study).Int J Ment Health Syst. 2019 Jun 7;13:40. doi: 10.1186/s13033-019-0298-3. eCollection 2019. Int J Ment Health Syst. 2019. PMID: 31182972 Free PMC article.
-
Cost-effectiveness of the SMILE intervention compared with usual care for people with severe mental illness: A randomized clinical trial.PLoS One. 2025 Jan 6;20(1):e0313100. doi: 10.1371/journal.pone.0313100. eCollection 2025. PLoS One. 2025. PMID: 39761242 Free PMC article. Clinical Trial.
-
Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.Qual Life Res. 2013 Jun;22(5):1055-63. doi: 10.1007/s11136-012-0222-7. Epub 2012 Jun 17. Qual Life Res. 2013. PMID: 22706728
-
A (five-)level playing field for mental health conditions?: exploratory analysis of EQ-5D-5L-derived utility values.Qual Life Res. 2018 Mar;27(3):717-724. doi: 10.1007/s11136-017-1768-1. Epub 2017 Dec 16. Qual Life Res. 2018. PMID: 29248995 Free PMC article.
-
Cost-effectiveness of the PDSAFE personalised physiotherapy intervention for fall prevention in Parkinson's: an economic evaluation alongside a randomised controlled trial.BMC Neurol. 2020 Aug 11;20(1):295. doi: 10.1186/s12883-020-01852-8. BMC Neurol. 2020. PMID: 32781987 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical